Efficient PEGylated Dendrimer Nanoplatform for Codelivery of Hyaluronidase and Methotrexate: A New Frontier in Chemotherapeutic Efficacy and Tumor Penetration-Reference-Cited by-同舟云学术

Efficient PEGylated Dendrimer Nanoplatform for Codelivery of Hyaluronidase and Methotrexate: A New Frontier in Chemotherapeutic Efficacy and Tumor Penetration

Published:2024-07-18 Issue:15 Volume:7 Page:17262-17277
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Soozanipour Asieh¹,Ejeian Fatemeh²,Razmjou Amir³^ORCID,Asadnia Mohsen⁴^ORCID,Nasr-Esfahani Mohammad Hossein²,Taheri-Kafrani Asghar¹^ORCID

Affiliation:

1. Department of Biotechnology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan 81746-73441, Iran

2. Department of Animal Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan 81746, Iran

3. Mineral Recovery Research Center (MRRC), School of Engineering, Edith Cowan University, Joondalup, Perth, WA 6027, Australia

4. Department of Engineering, Macquarie University, Sydney, New South Wales 2109, Australia

Funder

University of Isfahan

Biotechnology Development Council of the Islamic Republic of Iran

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsanm.4c01406

Reference55 articles.

1. PEGAylated graphene oxide/superparamagnetic nanocomposite as a high-efficiency loading nanocarrier for controlled delivery of methotrexate

2. Drug Stability and Chemical Kinetics

3. Mechanisms of Multidrug Resistance in Cancer Chemotherapy

4. Use of Half-Generation PAMAM Dendrimers (G0.5–G3.5) with Carboxylate End-Groups to Improve the DACHPtCl2 and 5-FU Efficacy as Anticancer Drugs

5. Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells